Ex vivo perfusion-based engraftment of genetically engineered cell sensors into transplantable organs.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31790444.
- Also identified by DOI 10.1371/journal.pone.0225222 and PMC identifier 6886851.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cellular rejection of liver transplant allografts remains a concern despite immunosuppressant use. Existing transplant biomarkers are often not sensitive enough to detect acute or chronic rejection at an early enough stage to allow successful clinical intervention. We herein developed a cell-based sensor that can potentially be used for monitoring local events following liver transplantation. Utilizing a machine perfusion system as a platform to engraft the cells into a donor liver, we effectively established the biocompatibility of the biosensor cells and confirmed efficient delivery of cells distributed throughout the organ. This work proves an innovative concept of integrating synthetic reporter cells ex vivo into organs as a transplant-within-a-transplant during functional organ preservation with a vision to use cell biosensors as a broad way to monitor and treat tissue transplants.
Medical subject headings
- Cell Engineering
- Cell- and Tissue-Based Therapy
- Fibroblasts
- Genetic Engineering
- Liver Transplantation
- Perfusion
- Transplants